Nothing Special   »   [go: up one dir, main page]

BRPI1009794A2 - marcadores genéticos de gravidade na esclerose múltipla - Google Patents

marcadores genéticos de gravidade na esclerose múltipla

Info

Publication number
BRPI1009794A2
BRPI1009794A2 BRPI1009794A BRPI1009794A BRPI1009794A2 BR PI1009794 A2 BRPI1009794 A2 BR PI1009794A2 BR PI1009794 A BRPI1009794 A BR PI1009794A BR PI1009794 A BRPI1009794 A BR PI1009794A BR PI1009794 A2 BRPI1009794 A2 BR PI1009794A2
Authority
BR
Brazil
Prior art keywords
severity
multiple sclerosis
genetic markers
markers
genetic
Prior art date
Application number
BRPI1009794A
Other languages
English (en)
Inventor
Esposito Federica
Abderrahim Hadi
Wojcik Jérôme
Debailleul Virginie
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of BRPI1009794A2 publication Critical patent/BRPI1009794A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00Reactions of nucleic acids characterised by
    • C12Q2531/10Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113PCR
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI1009794A 2009-03-27 2010-03-25 marcadores genéticos de gravidade na esclerose múltipla BRPI1009794A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09156487 2009-03-27
US16514109P 2009-03-31 2009-03-31
PCT/EP2010/053871 WO2010127906A1 (en) 2009-03-27 2010-03-25 Genetic severity markers in multiple sclerosis

Publications (1)

Publication Number Publication Date
BRPI1009794A2 true BRPI1009794A2 (pt) 2017-06-13

Family

ID=41601402

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009794A BRPI1009794A2 (pt) 2009-03-27 2010-03-25 marcadores genéticos de gravidade na esclerose múltipla

Country Status (14)

Country Link
US (1) US20120003182A1 (pt)
EP (1) EP2411533B1 (pt)
JP (1) JP2012521748A (pt)
KR (1) KR20110138395A (pt)
CN (1) CN102365370A (pt)
AU (1) AU2010244640A1 (pt)
BR (1) BRPI1009794A2 (pt)
CA (1) CA2749870A1 (pt)
EA (1) EA201171171A1 (pt)
ES (1) ES2569084T3 (pt)
IL (1) IL215377A0 (pt)
MX (1) MX2011010080A (pt)
SG (1) SG172988A1 (pt)
WO (1) WO2010127906A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110027417A1 (en) 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
KR101590622B1 (ko) 2013-10-24 2016-02-01 (주)메디컬그룹베스티안 화상 중증도 판단 방법
AU2016255437B2 (en) 2015-04-28 2020-10-08 Mars, Incorporated Process of preparing a sterilized wet pet food product
JP2021532060A (ja) * 2018-04-30 2021-11-25 シーダーズ—シナイ メディカル センター 炎症性疾患を抱える患者の選択および処置のための方法ならびにシステム
IT202000028628A1 (it) * 2020-11-26 2022-05-26 Ceinge Biotecnologie Avanzate S C A R L Metodo per prevedere la formazione di metastasi in pazienti tumorali
CN114255821B (zh) * 2021-12-31 2024-08-06 天津金域医学检验实验室有限公司 一种家系三样本高通量测序风险分组筛选方法及系统

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006076641A2 (en) * 2005-01-14 2006-07-20 Monosol Rx, Llc Methods and compositions for preventing and treating a disease related to glycan dysregulation

Also Published As

Publication number Publication date
EA201171171A1 (ru) 2012-07-30
WO2010127906A1 (en) 2010-11-11
US20120003182A1 (en) 2012-01-05
EP2411533B1 (en) 2016-03-23
AU2010244640A1 (en) 2011-08-11
CA2749870A1 (en) 2010-11-11
KR20110138395A (ko) 2011-12-27
SG172988A1 (en) 2011-08-29
CN102365370A (zh) 2012-02-29
IL215377A0 (en) 2011-12-29
ES2569084T3 (es) 2016-05-06
JP2012521748A (ja) 2012-09-20
EP2411533A1 (en) 2012-02-01
MX2011010080A (es) 2011-10-11

Similar Documents

Publication Publication Date Title
SMT201600104B (it) Inibitore di bromodominio benzodiazepinico
SMT201600081B (it) Inibitore di bromodominio di benzodiazepina
BRPI1006125A2 (pt) óculos
SMT201600307B (it) Composizione liposomiale
DK3078664T3 (da) Antiparasitiske dihydroazol-sammensætninger
FR2941462B1 (fr) Composition decapante
BRPI1013588A2 (pt) composição
BR112012005146A2 (pt) fotobiorreator
UY33161A (es) Composiciones plaguicidas
DOP2011000396A (es) Composiciones novedosas
BRPI1015474A2 (pt) composição
DK3346004T3 (da) Amylasepolypeptider
BRPI1008744A2 (pt) hidrotratamento de caboidratos
BR112012005382A2 (pt) inibidores de jak
BRPI1010690A2 (pt) composições
IT1397083B1 (it) Marcatore biochimico serico
BRPI1009018A2 (pt) fotobiorreator
BRPI1009794A2 (pt) marcadores genéticos de gravidade na esclerose múltipla
DK2519512T3 (da) N1-acyl-5-fluorpyrimidinonderivater
BRPI1011267A2 (pt) inibidores de protease
BRPI1005318A2 (pt) composição
FR2952847B3 (fr) >
BR112012002281A2 (pt) composicoes poliofinicas
DE112010002033B8 (de) Biohydrofuel-Zusammensetzungen
DK2405753T3 (da) Insektfrastødende sammensætning

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]